Latest filing published 19 Feb 2026 for GENTEX CORP.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Matthew Chiodo, listed as senior executive, appears in our data through filings on Gentex Corp shares, published by SEC (Form 4). Over a trading history stretching from 29 March 2018 to 19 February 2026, the count stands at 45 filings.
Both buying and selling appear: 7 purchases worth €25k, against 11 sales worth €1.8M. On balance, insiders were net sellers of €1.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 23 share grants and 4 option exercises. Since January 2026: no purchases and 2 sales on the market.
In size, the median ticket on the buying side is €2,233. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 19 February 2026 came the latest disclosure, a share grant in Gentex Corp. The clock since the last published purchase (30 June 2020) now reads 2,306 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations